Disclaimer: The views and opinions expressed in the articles contained in the Academy News are those of the identified authors and do not necessarily reflect the official policy or position of the Academy.
Source: Jonathan G. McGrath, PhD, MSFS, Senior Policy Analyst, National Institute of Justice
Please see the information below regarding the recently posted Department of Justice (DOJ) Bureau of Justice Assistance “Comprehensive Opioid Abuse Site-Based Program FY 2018 Competitive Grant Announcement.” An informational webinar is scheduled for Tuesday, May 15, 2018, at 1:00 p.m. – 2:30 p.m. EST and applications are due June 7, 2018.
In particular, please note that Category 6 projects that support information-sharing partnerships for access to timely and accurate data now also refer to multidisciplinary work with forensic science laboratories and medical examiner/coroner offices.
Category 6: Public Safety, Behavioral Health, and Public Health Information-Sharing Partnerships
To respond effectively to the opioid epidemic, stakeholders need access to timely and accurate data that provide a comprehensive view of the drug abuse environment. Unfortunately, data on drug abuse, treatment, and public safety outcomes are often maintained in different agencies and are not integrated in a way that supports the policy and practice needs of public safety, public health, or behavioral health partners. However, there are a growing number of models at the local and state levels that leverage information from a variety of public health and public safety data sources to analyze substance abuse issues and identify potential solutions from public health, treatment, and public safety perspectives. Specifically, models such as drug monitoring initiatives, overdose fatality review teams, and New York City’s RxStat Program (http://www.pdmpassist.org/pdf/RxStat.pdf) create an opportunity to bring together stakeholders with different perspectives and different data sets. This information can be used to drive changes in policy or practice, monitor community-level outcomes, and implement proven practices on a larger scale. Examples of successful projects in past years can be found at http://www.pdmpassist.org/content/data-driven-multi-disciplinary-approaches-reducing-rx-drugabuse-grants.
Mandatory Project Components and Deliverables for Category 6 include:
- Form a multidisciplinary action group that may include (but is not limited to) law enforcement representatives (this may include local law enforcement and/or High Intensity Drug Trafficking Area (HIDTA) Program or fusion center staff), the state or local health department, state medical and pharmacy boards, prosecutors, medical examiner/coroner offices, forensic science laboratories, probation and parole, drug court representatives, child welfare representatives, local drug treatment providers, and community organizations. Applicants must describe how they will collaborate with the Prescription Drug Monitoring Program (PDMP) to partner on grant activities, obtain relevant data sets, perform data analysis and assessment, and communicate with stakeholders.
Allowable uses include:
- Support the timely collection of data from medical examiner and coroner offices, forensic science laboratories (including seized drug analysis and toxicology analysis), and crime scenes and combine these data with other data sets, including fatal and non-fatal overdoses and PDMP records.
For assistance with any requirements of this solicitation, contact the National Criminal Justice Reference Service (NCJRS) Response Center: toll-free at 800–851–3420; via TTY at 301–240–6310 (hearing impaired only); email email@example.com; fax to 301–240–5830; or web chat at https://webcontact.ncjrs.gov/ncjchat/chat.jsp. The NCJRS Response Center hours of operation are 10:00 a.m. to 6:00 p.m. Eastern time, Monday through Friday, and 10:00 a.m. to 8:00 p.m. Eastern time on the solicitation close date.